0001209191-22-050094.txt : 20220915 0001209191-22-050094.hdr.sgml : 20220915 20220915170013 ACCESSION NUMBER: 0001209191-22-050094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220913 FILED AS OF DATE: 20220915 DATE AS OF CHANGE: 20220915 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Giberson Scott CENTRAL INDEX KEY: 0001937585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 221246354 MAIL ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 BUSINESS PHONE: 605-679-6980 MAIL ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-13 0 0001833214 SAB Biotherapeutics, Inc. SABS 0001937585 Giberson Scott 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 1 0 0 0 Employee Stock Option (right to buy) 0.71 2022-09-13 4 A 0 25000 0.00 A 2032-09-13 Common Stock 25000 25000 D Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. The shares underlying the option vest over a three-year period, vesting 1/36 monthly beginning with the month following the Reporting Person's commencement of service as a director (July 6, 2022). This represents the initial grant to the Reporting Person as a member of the Board of Directors. /s/ Scott Giberson 2022-09-15